Jennifer L Taubert Johnson & Johnson (JNJ) insider trading activity

Jennifer L Taubert is EVP, WWC. Innovative Medicine of JOHNSON & JOHNSON. Currently has a direct ownership of 170,459 shares of JNJ, which is worth approximately $27.7 Million. The most recent transaction as insider was on Feb 18, 2025, when has been sold 651 shares (Common Stock) at a price of $156.15 per share, resulting in proceeds of $101,653. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 170K

10.08% 3M change

10.08% 12M change

Total Value Held $27.7 Million

Jennifer L Taubert Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2025	SELL Payment of exercise price or tax liability	$101,653 $156.15 p/Share	651 Reduced 0.38%	170,459 Common Stock
Feb 15 2025	BUY Exercise of conversion of derivative security	-	1,594 Added 0.92%	171,110 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$1,510,587 $156.23 p/Share	9,669 Reduced 5.15%	178,013 Common Stock
Feb 14 2025	BUY Exercise of conversion of derivative security	-	19,518 Added 9.5%	185,924 Common Stock
Feb 13 2025	BUY Exercise of conversion of derivative security	-	1,302 Added 0.77%	167,221 Common Stock
Feb 07 2025	SELL Payment of exercise price or tax liability	$7,263,400 $153.12 p/Share	47,436 Reduced 22.23%	165,919 Common Stock
Feb 07 2025	BUY Exercise of conversion of derivative security	$5,853,910 $100.06 p/Share	58,504 Added 21.52%	213,355 Common Stock
Feb 13 2024	SELL Payment of exercise price or tax liability	$105,128 $157.85 p/Share	666 Reduced 0.43%	154,851 Common Stock
Feb 13 2024	BUY Exercise of conversion of derivative security	-	1,302 Added 0.83%	155,517 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$2,109,632 $157.4 p/Share	13,403 Reduced 8.0%	154,215 Common Stock
Feb 12 2024	BUY Exercise of conversion of derivative security	-	26,202 Added 13.52%	167,618 Common Stock
Feb 09 2024	SELL Open market or private sale	$9,281,969 $156.27 p/Share	59,397 Reduced 29.58%	141,416 Common Stock
Feb 09 2024	BUY Exercise of conversion of derivative security	$5,371,864 $90.44 p/Share	59,397 Added 22.83%	200,813 Common Stock
Feb 08 2024	SELL Payment of exercise price or tax liability	$299,059 $156.33 p/Share	1,913 Reduced 1.33%	141,416 Common Stock
Feb 08 2024	BUY Exercise of conversion of derivative security	-	3,739 Added 2.54%	143,329 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$1,712,283 $162.01 p/Share	10,569 Reduced 7.04%	139,590 Common Stock
Feb 13 2023	BUY Grant, award, or other acquisition	-	21,422 Added 12.49%	150,159 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$208,921 $162.08 p/Share	1,289 Reduced 0.99%	128,737 Common Stock
Feb 10 2023	BUY Exercise of conversion of derivative security	-	3,570 Added 2.67%	130,026 Common Stock
Nov 22 2022	SELL Open market or private sale	$13,598,447 $176.78 p/Share	76,923 Reduced 37.82%	126,456 Common Stock
Nov 22 2022	BUY Exercise of conversion of derivative security	$5,579,994 $72.54 p/Share	76,923 Added 27.44%	203,379 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$1,466,633 $165.89 p/Share	8,841 Reduced 6.53%	126,456 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	-	18,064 Added 11.78%	135,297 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$200,932 $168.85 p/Share	1,190 Reduced 1.0%	117,233 Common Stock
Feb 14 2022	BUY Exercise of conversion of derivative security	-	3,297 Added 2.71%	118,423 Common Stock

Also insider at

MCD

MCDONALDS CORP Consumer Cyclical

JLT